drugset

drugset / Trial / NCT00457470

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

NCT00457470 ↗

Phase 2 Withdrawn Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of AG-014699 in diabetic patients

Timeline

Start: 2007-06
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rucaparib	Small molecule	—	—

Indications